sodium butyrate
sodium butyrate is a pharmaceutical drug with 12 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
77.8%
7 of 9 finished
22.2%
2 ended early
1
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Butyrate Supplementation in Children With Autism Spectrum Disorder (ASD) and Functional Gastrointestinal Disorders
A Pharmacokinetic Comparison of Three Butyrate Products
Effect of Butyrate Supplement on Rheumatoid Arthritis
Intestinal Microbiome-based Research for the Prevention of Acute GVHD
Butyrate in Pediatric Inflammatory Bowel Disease
Clinical Trials (12)
Butyrate Supplementation in Children With Autism Spectrum Disorder (ASD) and Functional Gastrointestinal Disorders
A Pharmacokinetic Comparison of Three Butyrate Products
Effect of Butyrate Supplement on Rheumatoid Arthritis
Intestinal Microbiome-based Research for the Prevention of Acute GVHD
Butyrate in Pediatric Inflammatory Bowel Disease
Effect of Butyrate on Inflammation and Albuminuria in Patients With Albuminuria, Type 1 Diabetes and Intestinal Inflammation
Sodium Butyrate For Improving Cognitive Function In Schizophrenia
Effects of Butyrate Enemas on Colonic Health
Effects of Butyrate on Colonic Health of Patients With Diarrhoea Predominant IBS and UC in Remission
Sodium Butyrate For Improving Cognitive Function In Schizophrenia
Effect of a Butyrate Enema on the Systemic Concentration of Short Chain Fatty Acids
Therapeutic Induction of Endogenous Antibiotics
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12